Betűméret: A A A

Program – 2018

Semmelweis Symposium – 2018

Semmelweis Symposium 2018 program download

New approaches in personalized medicine: From prenatal testing to targeted tumor therapy

Budapest, November 8-9, 2018

Basic Science Center, Semmelweis University, Budapest (Tűzoltó 37-43, Budapest, 1094, Hungary)

Chairperson: Prof. Péter Lakatos

8th November

9.00-9.15

Opening ceremony

9.15-10.55

Section I. – Personalized Oncology I.

9.15-9.35

Personalized medicine: What does that mean? István Takács, Semmelweis University, Budapest, Hungary

9.35-9.55

Molecular biomarkers for the evaluation of colorectal cancer: Where are we now? Erika Tóth, Országos Onkológiai Intézet, Budapest, Hungary

9.55-10.15

Every breast cancer patient needs chemotherapy? Magdolna Dank, Semmelweis University, Budapest, Hungary

10.15-10.35

The role of RANK-RANKL in osteology and malignancies. Zsolt Nagy, Semmelweis University, Budapest, Hungary

10.35-10.55

The evolution of molecular pathology; precision medicine in practice. Chris Allen, ThermoFisher Scientific, UK

10.55-11.15

Coffee Break

11.15-12.55

Section II. – Personalized Oncology II.

11.15-11.35

The code and importance of liquid biopsy. Joao R. Carvalho, Biocartis, Mechelen, Netherlands

11.35-11.55

BRCA1/2 genes in clinical practice. Edit Oláh, National Institute of Oncology, Budapest, Hungary

11.55-12.15

The biology and application of cell-free nucleic acids in the clinical diagnosis. Bálint Nagy, Debrecen University, Debrecen, Hungary

12.15-12.35

Personalized approach to thyroid nodules. Juan Carlos Galofré, University of Navarra, Pamplona, Spain

12.35-12.55

Molecular diagnostics of thyroid cancers. Péter Lakatos, Semmelweis University, Budapest, Hungary

12.55-14.00

Lunch

14.00-15.20

Section III. – Prenatal genetics

14.00-14.20

Non-invasive prenatal testing (NIPT). János P. Kósa, Semmelweis University, Budapest, Hungary

14.20-14.40

SNP based NIPT, aneuploidy and single gene mutations. Trudy McKanna, Natera, San Carlos, CA, USA

14.40-15.00

Comparative genomic hybridization arrays or conventional karyotyping? Olga Török, Debrecen Egyetem, Debrecen, Hungary

15.00-15.20

Preimplantational diagnostics: designer babies? Péter Fancsovics, Semmelweis University, Budapest, Hungary

15.20-15.40

Graduated diagnosis and personalized therapy of rare diseases in pediatrics. György Fekete, Semmelweis University, Budapest, Hungary

15.40-16.00

Coffee Break

16.00-17.20

Section IV. – Endocrinology / Osteology

16.00-16.20

Sequential therapy of osteoporosis. Péter Lakatos, Semmelweis University, Budapest, Hungary

16.20-16.40

Treatment of diabetes by stem cells. Antony Gavalas, Dresden University of Applied Sciences, Dresden,Germany

16.40-17.00

Familial hypercholesterinemia – PCSK-9 inhibition. György Paragh, Debrecen University, Debrecen, Hungary

17.00-17.20

High throughput methods in the evaluation of tumorigenesis in endocrine tumors. Attila Patócs, Semmelweis University, Budapest, Hungary

 

 

19.00-22.00

Official Dinner Event (River Danube Experience)

9th November

9.00-10.40

Section V. – Hematology

9.00-9.20

BITE-ing in the leukemia. Judit Demeter, Semmelweis University, Budapest, Hungary

9.20-9.40

Personalized diagnostics and therapy in oncohematological malignancies. Csaba Bödör, Semmelweis University, Budapest, Hungary

9.40-10.00

NGS in hematology. Torsten Haferlach, Münchner Leukämielabor, München, Germany

10.00-10.20

Chimeric Antigen Receptor (CAR) T-Cell Therapy in hematology. Tamás Masszi, Semmelweis University, Budapest, Hungary

10.20-10.40

Virus-specific T cell therapy in allogenic hematopoietic stem cell transplantation. Krisztián Kállay, Dél-Pesti Medical Center and National Institute for Hematology and Infectology, Budapest, Hungary

10.40-11.00

Coffee Break

11.00-13.00

Section VI. – Rare diseases

11.00-11.20

Langerhans cell histiocytosis – from inflammation to malignancy. Michael Girschikofsky, Ordensklinikum, Linz, Austria

11.20-11.40

Ending the diagnostic odyssey of rare diseases: NGS in the clinic. Kristóf Árvai, Semmelweis University, Budapest, Hungary

11.40-12.00

Enzyme replacement therapies for lysosomal storage diseases. Francisca Coutinho, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal

12.00-12.20

Live and let die. What genetics can offer for patients with cardiac disease: blessing or damn? Gábor Uzonyi, Uzsoki Hospital, Budapest, Hungary

12.20-12.40

Whole exome sequencing in the management of rare diseases. Judit  Mária Molnár, Semmelweis University, Budapest, Hungary

12.40-13.40

Lunch

13.40-15.20

Section VII. – Emerging Techniques

13.40-14.00

Cell metabolism revealed: Agilent Seahorse XF, Svetoslav Kalaydiev, Agilent, Stockport, UK

14.00-14.20

CRISPR / Base editing. Marie-Christine Birling, Institute Clinique de la Souris, Illkirch-Graffenstaden, France

14.20-14.40

Lessons from limb regeneration in salamanders. Dunja Knapp, DFG- Center for Regenerative Therapies Dresden, Dresden, Germany

14.40-15.00

Nanostring digital optical barcode technology: innovations in spatially resolved, library free multi-analyte expression analysis. Dr. Christoph Koenig, Nanostring Technologies, Seattle

15.00-15.10

Closing remarks by Prof. Peter Lakatos